
上市后監(jiān)督總監(jiān)

職位描述
工作職責(zé):
This new position of Director, Post Market Surveillance (PMS) is accountable for overall strategy, execution and oversight of all activities associated with complaint handling associated quality management systems, functions and regulatory compliance reporting of Adverse Events (AEs) and Medical Device Reportable (MDRs) throughout the product life cycle for MicroPort Cardiovascular business, globally.
? This key leadership role is to ensure governmental regulatory requirements are met, customer experiences are appropriately logged and investigated to both comply with laws/regulations. This position will facilitate proactive quality and associated improvements in customer experience, as well as to ensure the organization is informed of adverse trending through analysis of complaints for Adverse Events, Medical Device Reportable, including tracking and trending.
? Direct leadership accountability and oversight of activities such as (a) uptake and logging of customer complaints, (b) their proper and thorough investigation and subsequent documentation, (c) statistical tracking and trending and associated evaluation and escalation of adverse customer complaint trends and early identification of new issues (with priority on safety issues), (d) proper evaluation of safety and patient risk through overall administration of a Health Hazard Evaluation (HHE) process, and (e) AE and MDR reporting, and the associated timeliness.
? Assures compliance with regards to AE/MDR with the applicable international regulatory requirements (ie, FDA QSRs, ISO 13485, Japanese MHLW, Brazilian ANVISA, EU MDR) for the company
s products, including medical devices, and combination products. Ensures successful internal and external inspections and audits.
? Ensure timeliness of all complaint handling, adverse events, and medical device reporting activities in accordance to procedures, standards and regulations.
? Responsible and accountable for the compliance of all PMS processes and procedures, associated document and performance metrics.
企業(yè)簡介
上海微創(chuàng)醫(yī)療器械(集團(tuán))有限公司為中國領(lǐng)先的醫(yī)療器械開發(fā)商、制造商及營銷商,主要專注于治療血管疾病及病變的微創(chuàng)介入產(chǎn)品。集團(tuán)于2010年9月于香港聯(lián)合交易所上市,股份編號:00853。
集團(tuán)主要供應(yīng)心血管器械和其他血管器械以及糖尿病器械,主要產(chǎn)品為第二代鈷鉻合金藥物洗脫支架 Firebird 2。集團(tuán)還供應(yīng)其他血管支架,用于治療身體其他部位的血管疾病及失調(diào)。集團(tuán)亦銷售極其細(xì)小的顱內(nèi)支架、用于促進(jìn)腦血管血液流量的靈活支架以及外科手術(shù)中使用的覆膜支架。
微創(chuàng)的產(chǎn)品于中國有逾1,100家醫(yī)院使用,部分產(chǎn)品出口至中國境外的20多個位于亞太地區(qū)(不包括中國)、南美及歐洲的國家。
有冠脈藥物支架系統(tǒng)、冠脈金屬支架系統(tǒng)、顱內(nèi)動脈支架系統(tǒng)、腹主動脈瘤和胸主動脈瘤等支撐型人造血管支架、球囊(PTCA)擴張導(dǎo)管、導(dǎo)引導(dǎo)管及其相關(guān)附件、胰島素泵、骨科產(chǎn)品、射頻消融電生理導(dǎo)管等醫(yī)療器械;它們中絕大多數(shù)填補國內(nèi)空白,被認(rèn)定為上海市高新技術(shù)成果轉(zhuǎn)化項目,達(dá)國際先進(jìn)水平,直接與國外產(chǎn)品競爭,已進(jìn)入中國各大知名醫(yī)院,并出口日本、歐洲、拉美等國家與地區(qū),具有一定的品牌知名度和市場占有率。
職位發(fā)布企業(yè)

上海微創(chuàng)骨科醫(yī)療科技有限公司
企業(yè)性質(zhì):外資企業(yè)
企業(yè)規(guī)模:1-49人
成立年份:2009
企業(yè)網(wǎng)址:www.ileadfilms.net
企業(yè)地址:1
該企業(yè)其他職位更多>>
相關(guān)職位推薦
上海相關(guān)職位: 銷售經(jīng)理(新生兒、醫(yī)療) 銷售經(jīng)理(呼吸醫(yī)療) 工藝員 微生物檢驗員 維系保養(yǎng)員/電工 (MJ002499) QA體系專員 驗證專員/主管 QC化學(xué)分析員 (MJ002498) QA質(zhì)量管理員(體系/驗證/注冊)
熱門區(qū)域招聘: 重慶 北京 上海 浙江 江蘇 廣東 山東 湖南 安徽 河北
上海招聘企業(yè): 上海拓康方舟醫(yī)療科技有限公司 易葫蘆(上海)醫(yī)藥科技有限公司 百進(jìn)冠合(海南) 醫(yī)療科技有限公司 上海華茂藥業(yè)有限公司 上海信誼藥廠有限公司 上海強生制藥 歐姆龍健康醫(yī)療(中國)有限公司 青海瑞成藥業(yè)(集團(tuán))有限公司 上海交通大學(xué)醫(yī)學(xué)院附屬瑞金醫(yī)院 復(fù)旦大學(xué)附屬中山醫(yī)院
職位發(fā)布日期: 2019-05-16